pyrroles has been researched along with Thyroid Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lammertsma, AA; Smit, EF; van der Veldt, AA | 1 |
| Faivre, S; Grande, E; Hubner, RA; Raymond, E; Valle, JW | 1 |
| Atzori, F; Baghino, G; Boi, F; Ionta, MT; Mariotti, S; Pani, F; Tanca, L | 1 |
| Daimon, M; Kaino, W; Kameda, W; Karasawa, S; Kato, T; Oizumi, T; Susa, S; Takase, K; Tomita, Y; Wada, K | 1 |
| Krzemieniecki, K; Sowa-Staszczak, A; Zygulska, AL | 1 |
| Iiri, T; Makita, N | 1 |
| Borbely, A; Mezosi, E; Nagy, EV; Paragh, G; Szabo, J; Varga, E; Varga, Z | 1 |
2 review(s) available for pyrroles and Thyroid Diseases
| Article | Year |
|---|---|
Hypothyroidism during treatment with tyrosine kinase inhibitors.
Topics: Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Gastrointestinal Neoplasms; Humans; Indoles; Kidney Neoplasms; Liver Neoplasms; Neoplasm Metastasis; Neoplasms; Niacinamide; Phenylurea Compounds; Pyrroles; Sorafenib; Sunitinib; Thyroid Diseases; Thyroid Function Tests; Thyroid Gland; Thyroid Neoplasms | 2012 |
Tyrosine kinase inhibitor-induced thyroid disorders: a review and hypothesis.
Topics: Humans; Hypothyroidism; Indoles; Neovascularization, Pathologic; Protein Kinase Inhibitors; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Platelet-Derived Growth Factor; Sunitinib; Thyroid Diseases; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
5 other study(ies) available for pyrroles and Thyroid Diseases
| Article | Year |
|---|---|
Reduction in thyroid perfusion after bevacizumab treatment.
Topics: Humans; Indoles; Protein Kinase Inhibitors; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Platelet-Derived Growth Factor; Thyroid Diseases; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2013 |
Practical management of sunitinib toxicities in the treatment of pancreatic neuroendocrine tumors.
Topics: Antineoplastic Agents; Cardiovascular Diseases; Drug Administration Schedule; Fatigue; Hand-Foot Syndrome; Humans; Indoles; Neuroendocrine Tumors; Neutropenia; Pancreatic Neoplasms; Pyrroles; Stomatitis; Sunitinib; Thyroid Diseases | 2014 |
Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?
Topics: Adult; Aged; Antineoplastic Agents; Autoantibodies; Autoimmunity; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Prospective Studies; Pyrroles; Sunitinib; Thyroglobulin; Thyroid Diseases; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 2015 |
Thyroid dysfunction in patients treated with tyrosine kinase inhibitors, sunitinib, sorafenib and axitinib, for metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Axitinib; Benzenesulfonates; Carcinoma, Renal Cell; Female; Humans; Imidazoles; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrroles; Sorafenib; Sunitinib; Thyroid Diseases; Thyroid Gland; Thyrotoxicosis | 2012 |
Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes.
Topics: Adult; Aged; Case-Control Studies; Cell Culture Techniques; Chelating Agents; Diiodothyronines; Dose-Response Relationship, Drug; Egtazic Acid; Female; Free Radicals; GTP-Binding Proteins; Humans; Hyperthyroidism; Hypothyroidism; Indoles; Iodine Radioisotopes; Middle Aged; Naphthalenes; Neutrophil Activation; Neutrophils; Peroxidase; Pertussis Toxin; Protein Kinase C; Pyrroles; Reactive Oxygen Species; Stimulation, Chemical; Superoxides; Thyroid Diseases; Thyroid Hormones; Thyroxine; Triiodothyronine | 2005 |